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ABSTRACT 
Following the request from the European Commission, the Panel on Genetically Modified Organisms of the 
European Food Safety  Authority (EFSA GMO Panel) assessed the  monitoring report for the 2011 growing 
season of maize MON 810 provided by Monsanto Europe S.A. The EFSA GMO Panel already assessed the 2009 
and 2010 monitoring reports and followed the same approach as for the assessment of the methodology applied 
by the applicant for monitoring maize MON 810 in 2011. The EFSA GMO Panel considered the plan for insect-
resistant management and addressed the comments raised by the applicant on its previous recommendations for 
improving  the  methodology  of  the  resistance  monitoring  of  target  pests.  The  EFSA  GMO  Panel  also  paid 
particular attention to the design and analysis of the farmer questionnaires. The EFSA GMO Panel notes similar 
shortcomings in the overall methodology for the post-market environmental monitoring of maize MON 810 as in 
the previous monitoring reports. Hence, while the EFSA GMO Panel reiterates its previous recommendations for 
the  improvement  of  the  methodology,  it  also  clarifies  and  elaborates on  those  related  to  the  monitoring  of 
resistance evolution in target pests. However, from the data submitted by the applicant, the EFSA GMO Panel 
does  not  identify  adverse  effects  on  the  environment,  human  and  animal  health  due  to  maize  MON  810 
cultivation during the 2011 growing season. The outcomes of the 2011 monitoring report do not invalidate the 
previous EFSA GMO Panel‟s scientific opinions on maize MON 810. 
© European Food Safety Authority, 2013 
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SUMMARY 
Upon request from the European Commission, the Panel on Genetically Modified Organisms of the 
European Food Safety Authority (EFSA GMO Panel) adopted a scientific opinion on the Post-Market 
Environmental  Monitoring  (PMEM)  report  of  maize  MON  810  for  the  2009  and  2010  growing 
seasons provided by Monsanto Europe S.A., on 7 September 2011 and 7 March 2012 respectively. 
During  its  assessment  of  the  2009  and  2010  PMEM  reports,  the  EFSA  GMO  Panel  identified 
shortcomings in the methodology for both Case-Specific Monitoring (CSM) and General Surveillance 
(GS) of maize MON 810 and hence provided recommendations for improvement of the PMEM of 
maize MON 810.  
In response to a similar request from the European Commission to assess the PMEM report of maize 
MON  810  for  the  2011  growing  season,  the  EFSA  GMO  Panel  firstly  noted  that  the  applicant 
followed the same methodological approach as in its previous reports. Therefore, the EFSA GMO 
Panel mainly assessed the datasets specific to the 2011 growing season, i.e. observations from farmer 
questionnaires, data from a survey in Spain on refugia compliance and outcomes of the literature 
search. In addition, the EFSA GMO Panel addressed the points raised by the applicant regarding its 
recommendations to improve the methodology for the monitoring of resistance evolution in target 
pests. 
From its assessment of the methodology applied by the applicant for the monitoring of maize MON 
810 in 2011, the EFSA GMO Panel notes similar shortcomings as in the previous reports. Hence, the 
EFSA GMO Panel reiterates the same recommendations for improvement of the methodology as in its 
scientific opinions on the 2009 and 2010 PMEM reports. Moreover, in light of the points raised by the 
applicant, the EFSA GMO Panel clarified and elaborated on some of its previous recommendations on 
the methodology supporting the monitoring for resistance evolution of target pests.  
However, from the data submitted by the applicant, the EFSA GMO Panel does not identify adverse 
effects on the environment, human and animal health due to maize MON 810 cultivation during the 
2011 growing season. The outcomes of this 2011 PMEM report do not invalidate the previous EFSA 
GMO Panel‟s scientific opinions on maize MON 810.  Scientific Opinion on 2011 Monsanto PMEM report on GM maize MON 810  
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION AND EFSA 
Genetically Modified (GM) maize MON 810 (notification reference C/F/95/12-02) was authorised 
under Directive 90/220/EEC (EC, 1990) in the European Union (EU) for all uses (with the exception 
of food uses) by the Commission Decision 98/294/EC (EC, 1998). A final consent was granted to the 
applicant (Monsanto Europe S.A.) by France on 3 August 1998. Food uses of maize derivatives were 
notified according to Article 5 of the Novel Food Regulation (EC) No 258/97 on 6 February 1998. 
Following the request by the applicant for the renewal of the authorisation for placing maize MON 
810  on  the  market,  the  EFSA  GMO  Panel  adopted  a  scientific  opinion  on  the  renewal  under 
Regulation (EC) No 1829/2003 of maize MON 810 for import, processing for food & feed uses and 
cultivation in June 2009 (EFSA GMO Panel, 2009). The EFSA GMO Panel concluded that ´maize 
MON 810 is unlikely to have any adverse effect on the environment in the context of its intended uses, 
especially if appropriate management measures are put in place in order to mitigate possible exposure 
of non-target (NT) Lepidoptera´. The EFSA GMO Panel recommended that, especially in areas of 
abundance of non-target Lepidoptera populations, the adoption of the cultivation of maize MON 810 
be accompanied by management measures in order to mitigate the possible exposure of these species 
to maize MON 810 pollen. In addition, the EFSA GMO Panel advised that resistance management 
strategies continue to be employed and that the evolution of resistance in lepidopteran target pests 
continues to be monitored in order to detect potential changes in resistance levels in pest populations. 
The EFSA GMO Panel agreed with the overall approach and methodology proposed by the applicant 
for general surveillance, but advised the applicant to describe in more detail how information will be 
collected that could be used to assess if the intended uses of maize MON 810 are having unanticipated 
adverse environmental effects.  
From 2005 onwards, the applicant submitted to the European Commission  PMEM reports on the 
cultivation of maize MON 810 according to the provisions of Directive 2001/18/EC (EC, 2001).  
From 2010 onwards, the EFSA GMO Panel received the requests from the European Commission to 
assess the PMEM reports submitted by Monsanto on the cultivation of maize MON 810 in 2009 and 
2010. The EFSA GMO Panel therefore adopted a scientific opinion on these PMEM reports on 7 
September 2011 and 7 March 2012, respectively (EFSA GMO Panel, 2011b, 2012a). The EFSA GMO 
Panel noted shortcomings in the methodology and hence made recommendations for improvement of 
the PMEM of maize MON 810. However, from the data submitted by the applicant, the EFSA GMO 
Panel did not identify adverse effects on the environment, human and animal health due to maize 
MON 810 cultivation in 2009 and 2010.  
On 14 May 2013, the EFSA GMO Panel received from the European Commission a request to assess 
the PMEM report submitted by Monsanto on the cultivation of maize MON 810 in 2011 taking into 
consideration comments from Member States on the report as well as points raised by the applicant on 
its previous assessment of the methodology for case-specific monitoring.  
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION AND EFSA 
On 21 May 2013, the EFSA GMO Panel received a request from the European Commission (EC): (1) 
to evaluate the findings of the monitoring activities reported in the 2011 PMEM report on maize MON 
810, taking into consideration the comments from Member States; (2) to assess the appropriateness of 
the methodology if this is found to differ compared to the previous season; and (3) to address the 
points raised by the applicant.
4  
                                                       
4 See Section „Documentation provided to EFSA‟ Scientific Opinion on 2011 Monsanto PMEM report on GM maize MON 810  
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ASSESSMENT 
1.  Introduction 
Maize MON 810 was developed by the applicant, Monsanto Europe S.A., to express the Cry1Ab 
protein, derived from Bacillus thuringiensis subsp. kurstaki (Bt), which confers protection against the 
lepidopteran target pests European corn borer (ECB; Ostrinia nubilalis Hübner) and Mediterranean 
corn borer (MCB; Sesamia nonagrioides Lefebvre). In 2011, maize MON 810 was cultivated in the 
EU, i.e. in the Czech Republic, Poland, Spain, Portugal, Romania and Slovakia.  
The applicant reports to the European Commission and Member States on an annual basis the results 
of its monitoring activities on the cultivation of maize MON 810 in the EU. In preparing the present 
scientific opinion, the EFSA GMO Panel made the best use of its previous assessments of the 2009 
and 2010 reports (EFSA GMO Panel, 2011b, 2012a) and considered, for example, relevant peer-
reviewed publications and comments from Member States on the 2011 report.  
Considering the timeline, the EFSA GMO Panel acknowledges that the applicant could not have fully 
implemented the Panel‟s recommendations on PMEM, as referred to in its scientific opinion on the 
2010  report,  in  the  2011  monitoring  scheme  for  maize  MON  810  (EFSA  GMO  Panel,  2012a). 
Therefore, because the applicant had used the same methodological approach as in its previous reports, 
the EFSA GMO Panel mainly assessed the novel datasets specific to the 2011 growing season, i.e. 
questionnaires  answered  by  selected  farmers  in  the  EU  countries  where  maize  MON  810  was 
cultivated  in  2011,  data  from  a  specific  survey  on  refugia  compliance  by  Spanish  farmers  and 
outcomes  of  the  search  or  peer-reviewed  publications  on  the  safety  of  maize  MON  810  and  the 
Cry1Ab  protein.  In  addition,  the  EFSA  GMO  Panel  addressed  the  points  raised  by  the  applicant 
regarding its recommendations to improve the methodology for resistance monitoring of target pests. 
The EFSA GMO Panel, in close collaboration with the EFSA Unit for Scientific Assessment Support 
(EFSA SAS Unit), assessed the appropriateness of the methodology for the farmer survey as part of 
the general surveillance of maize MON 810 (see Appendix B). 
2.  Case-Specific Monitoring (CSM) 
2.1.  Summary of the information provided by the applicant 
As  in  its  previous  reports,  the  applicant  submitted  an  insect  resistance  management  (IRM)  plan 
developed  from  the  approach
5  described  by  the  industry -based  EU  Working  Group  on  Insect 
Resistance Management. The IRM plan for maize MON 810 therefore consists of: 
(1)  a strategy based on a high dose of Cry protein accompanied by non-Bt refugia in order to 
delay the potential evolution of resistance of the target pests (ECB and MCB) to maize MON 
810.  Moreover,  farmers‟  satisfaction  and  compliance  with  refugia  implementation  were 
assessed through a specific survey
6 in Spain; 
(2)  studies to establish the baseline susceptibility for target pest population(s) and the subsequent 
proposed strategy for monitoring their possible resistance evolution; 
(3)  communication  with  farmers  (e.g.  a  technical  user  guide
7)  and  a  proactive  education 
programme for farmers on compliance with implementation of refugia (e.g. letters, interviews 
and press articles, leaflets); 
(4)  a remedial action plan in the event of any confirmed evolution of pest resistance. 
                                                       
5 MON 810 2011 PMEM report, Appendix 6.  
6 MON 810 2011 PMEM report, section 3.2.1.1. 
7 MON 810 2011 PMEM report, Appendices 3.1 to 3.6 Scientific Opinion on 2011 Monsanto PMEM report on GM maize MON 810  
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For  further  details,  please  consult  the  2011  report  published  at 
http://ec.europa.eu/food/plant/gmo/reports_studies/report_2011_mon_810_en.htm.   
Moreover, the applicant
8 made several points regarding previous recommendations of the EFSA GMO 
Panel for the improvement of the methodology for  resistance monitoring of target pests (see section 
2.3 of EFSA GMO Panel, 2012a). The applicant confirmed the relevance and appropriateness of the 
proposed 1-5 % range of resistance allele  frequency aiming at  early detection of resistance, sought 
clarifications of the concept of „hotspot‟ as defined in previous opinions from the EFSA GMO Panel; 
and  claimed  that  scouting  pest  larvae  on  Bt-plants  is  not  cost-effective.  Moreover,  the  applicant 
questioned the need for improved training of growers on non-Bt refugia compliance as well as the 
need to monitor regionally occurring pests other than ECB and MCB.  
2.2.  Assessment by the EFSA GMO Panel 
In general, the EFSA GMO Panel evaluated to what extent the monitoring protocols designed by the 
applicant  ´allow  for  early  detection  of  potential  pest  resistance  before  field  failures  occur  and 
therefore enable additional management measures to be effectively implemented in a timely manner´ 
(see harmonized IRM plan
9 for cultivation of Bt-maize in the EU).  
 
Given the similarities of the methodology applied for maize MON 810 monitoring in 2009 and 2010, 
the EFSA GMO Panel mostly refers to the conclusions and recommendations in its previous scientific 
opinions (EFSA GMO Panel, 2011b, 2012a). Nevertheless, in light of applicant‟s concerns, the EFSA 
GMO  Panel  clarified  and  provided  additional  supporting  information  for  some  of  its  previous 
recommendations for improvement of the methodology for the monitoring of resistance evolution. 
2.2.1.  High-dose/refuge strategy 
2.2.1.1.  High dose 
As in its scientific opinions on the previous maize MON 810 reports (EFSA GMO Panel, 2011b, 
2012a), the EFSA GMO Panel agrees with the applicant that appropriate IRM strategies are capable of 
delaying the evolution of resistance under field conditions (Alstad and Andow, 1995; Andow, 2008; 
Tabashnik  et  al.,  2008,  2009,  2013).  Furthermore,  the  EFSA  GMO  Panel  is  not  aware  of  new 
information on Cry1Ab expression levels in maize MON 810 that would invalidate the efficiency of 
the „high-dose/refuge strategy‟ for the two major European target pests, namely O. nubilalis and S. 
nonagrioides.  
The EFSA GMO Panel also considers that, as the larvae of other regionally occurring non-target 
lepidopteran  pests  (e.g.  Helicoverpa  armigera,  Agrotis,  Mythimna  spp.)  will  be  exposed  to 
lepidopteran active Bt-toxin(s) through their feeding on maize plants, they have the potential to evolve 
resistance to these toxins (EFSA GMO Panel, 2012a).  
In addition, the EFSA GMO Panel wishes to stress that it is very difficult to assess the likely efficacy 
of  maize  MON  810  high-dose/refuge  strategy  (as  developed  for  the  target  pests)  for  regionally 
occurring non-target lepidopteran pests. For an assessment of whether this refuge strategy will work 
on these species, additional information on all underlying assumptions of the strategy are important . It 
is possible that exploitation of Bt-maize to control/reduce the density of these regionally occurring 
non-target  lepidopteran  pests  may  happen  in  some  regions.  The  EFSA  GMO  Panel  reiterates  its 
previous recommendation to ´consider regionally important lepidopteran pests (other than ECB and 
MCB) of maize MON 810 in the context of CSM for IRM strategy´. However, accounting for the 
aspects concerning host-plant spectrum, biology, migratory behaviour, and the sporadic occurrence of 
                                                       
8 See Section „Documentation provided to EFSA‟ 
9 MON 810 2011 PMEM report, Appendix 6 Scientific Opinion on 2011 Monsanto PMEM report on GM maize MON 810  
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these regionally occurring pests, the spatial and temporal exposure of their larvae to Cry1Ab protein is 
likely to be less than that of target pests and lead to reduced selection pressure on these species.  
Therefore, the EFSA GMO Panel suggests that the applicant uses farmer questionnaires as a tool to 
give early-warning of the potential for resistance evolution in populations of these non-target pests by 
reporting  observations  on  the  occurrence  and  unexpected  survival  (and  possible  damage)  of  their 
larvae on Bt-maize plants. In the event that farmers report indications of possible resistance evolution 
in these regionally occurring non-target lepidopteran pests, they should be considered for inclusion in 
the routine IRM plan (for further details, see EFSA GMO Panel, 2012b).  
In general, before the onset of resistance, regionally occurring non-target lepidopteran pests should be 
controlled  by  appropriate  integrated  pest  management  (IPM)  measures.  Against  this  background, 
under  the  communication  and  education  programme  set  up  by  the  applicant,  farmers  should  be 
informed of the need to apply IPM measures (see section 2.2.3).  
2.2.1.2.  Implementation of non-Bt refugia 
The  EFSA  GMO  Panel  analysed  the  results  of  the  survey  by  ANTAMA  addressing  the 
implementation of non-Bt refugia by 100 Spanish farmers (from the Ebro Valley) who cultivated 
maize MON 810 in 2011. It concluded that 7 % of the farmers growing maize MON 810 in 2011 did 
not plant a refuge area. The reasons given by the farmers for not planting a refuge area were (1) ECB 
causes significant economic losses; (2) sowing is easier (with Bt-maize); (3) they considered their 
farms to be small farms (i.e. less than 5 ha and therefore no refuge is required). The EFSA GMO Panel 
points out some inconsistencies in reporting data from the ANTAMA survey. For future reports, the 
EFSA  GMO  Panel  recommends  that  the  applicant  provides  a  rationale  justifying  possible 
inconsistencies or the raw data from the survey as recommended by the EFSA guidance document on 
PMEM of GM plants (EFSA GMO Panel, 2011a). 
The EFSA GMO Panel notes an improvement of the percentage of farmers complying with the refugia 
implementation over the years (i.e. 81 % in 2009, 88 % in 2010, 93 % in 2011). However, the 2011 
MON 810 report still shows partial non-compliance with the implementation of non-Bt refugia in 
Spain,  which  was  further  confirmed  by  the  farmer  questionnaires.
10  The  EFSA  GMO  Panel 
recommends  that  the  applicant  should  not reduce  its  efforts  to increase the level of compliance , 
especially in regions of high maize MON 810 uptake.  
2.2.2.  Baseline susceptibility studies and proposed strategy for resistance monitoring of target 
pests 
The  harmonised  IRM  plan
11  for  cultivation  of  Bt -maize  in  the  EU   consists  in  two  steps:  (i) 
measurement of baseline susceptibility and (ii) detection of the frequency of resistance alleles. 
2.2.2.1.  Establishment of baseline susceptibility  
In the first instance, the applicant has been establishing baseline susceptibility data since 2005 for 
ECB populations in the Czech Republic (5 populations), France (16), Germany (9), Hungary (1), Italy 
(8), Poland (3), Portugal (2), Slovakia (6), Romania (17) and Spain (18) as well as for three pooled 
MCB populations from Portugal and Spain. In 2011, ECB larvae were sampled in Spain, Romania, the 
Czech Republic, Germany and Poland whereas MCB larvae were collected in North-East Iberia.  
The  susceptibility  of  ECB
12  and MCB
13  to Cry1Ab protein was assessed by the applicant in a 
laboratory colony and in larval samples collected from refugia areas and fields adjacent to Bt-maize in 
                                                       
10 MON 810 2011 PMEM report, Appendix 1 
11 MON 810 2011 PMEM report, Appendix 6 
12 MON 810 2011 PMEM report, Appendix 8 
13 MON 810 2011 PMEM report, Appendix 7 Scientific Opinion on 2011 Monsanto PMEM report on GM maize MON 810  
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the aforementioned EU countries. To detect changes in susceptibility to maize MON 810 in ECB and 
MCB populations, the applicant used the same methods employed in its previous reports: mortality 
assessed to determine the lethal concentrations (LC) and/or growth inhibition assessed for the molting 
inhibition concentrations (MIC).  
The EFSA GMO Panel is of the opinion that, in addition to the data available in the scientific literature 
(e.g.  González-Núñez  et  al.,  2000;  Farinós  et  al.,  2011;  Saeglitz  et  al.,  2006),  the  applicant  has 
established an appropriate dataset on the baseline susceptibility of the target pests in Europe.  
2.2.2.2.  Proposed strategy for resistance monitoring of target pests  
Once regular measurement of the susceptibility baseline is implemented, changes in the frequency of 
resistance alleles should also be reported. The applicant suggests a methodological approach based on 
a discriminating dose assay  according to Hawthorne et al. (2001) and Marçon et al.  (2000). The 
applicant states that the resistance monitoring aims at detecting a frequency of the resistance allele 
ranging from 1 to 5 %.  
During its assessment of the 2009 report on maize MON 810 (see Appendix 2 to EFSA GMO Panel, 
2011b), the EFSA GMO Panel made use of a theoretical model by Alstad and Andow (1995) in order 
to estimate the resistance allele frequency indicating the onset of resistance. In EFSA (2011b, 2012a), 
the EFSA GMO Panel concluded that the detection of resistance alleles should be clearly less than 5 % 
(i.e. between 1 and 3 %). In order to further support and to precise its previous recommendations to 
the  applicant,  the  EFSA  GMO  Panel  used  the  same  model  to  run  additional  simulations  with 
increasing values of the different parameters.  
The EFSA GMO Panel conducted further simulations with the aim of giving more detailed indications 
on  CSM  plans  and  also  provided  support  on  the  effectiveness  of  possible  mitigation  measures. 
Additional  simulations  considered  a  range  of  different  scenarios  for  various  parameters,  such  as 
adoption rate of maize MON 810, initial frequency of the resistance allele, sampling frequency and 
target pests (i.e. bivoltine ECB populations). For each scenario, the aim was to estimate the number of 
generations required  to reach  an  allele frequency  of  0.5  in  the  target  insect population,  once  the 
resistance allele frequency detected during CSM had reached 1, 3 or 5 %. The main outcomes are 
summarised in Appendix A. 
According to the results of the model, in the case of a very sensitive annual sampling plan aimed at 
detecting an occurrence of 0.01 allele frequency in the population of the target insect, even at a very 
high adoption rate (i.e. 80 %), there is enough time to implement contingency plans before resistance 
occurs in the field. However, in the case of very high adoption rates, a drastic reduction in maize 
MON 810 cultivation is needed to significantly delay insect resistance (see Table 1).  
When a detection limit of 0.05 is set, it appears that a successful contingency plan can be efficiently 
applied only for annual samplings and in the case of low to medium adoption rates up to 50 %. A 
detection limit of an allele frequency of 0.03 increases the time to react for low and medium rates of 
adoption.  
When considering the possibility of implementing biennial sampling plans, the results indicate that the 
detection of a 0.05 allele frequency can be applied only for low adoption rate up to 40 %. Even the 
0.03 detection limit can be applied only if the adoption rate does not exceeds 40 %. Over 40 %, a 
biennial sampling plan is acceptable only when a detection limit of an allele frequency of 0.01 is the 
aim and for an adoption rate of maize MON 810 up to 50 %. 
The EFSA GMO Panel concludes that, in regions of high uptake of maize MON 810 (e.g. 60 % to 
80 % uptake in Catalunya), the detection level of 5 % resistance allele, as suggested by the applicant, 
is not acceptable. Therefore, the EFSA GMO Panel suggests that, an efficient monitoring programme 
should be aimed at detecting an allele frequency below 0.03 with sufficient confidence for maize Scientific Opinion on 2011 Monsanto PMEM report on GM maize MON 810  
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MON 810 adoption rates lower than 50 %. In the case of higher adoption rates, a detection limit of 
0.01 is deemed necessary. 
In  the  case  of  monovoltine  ECB  populations,  the  time  available  to  react  is  longer  and  therefore 
monitoring programs can be revised accordingly. For monitoring plans with Sesamia spp., the possible 
occurrence of multivoltine populations in this species makes the need for annual sampling plans even 
more important. 
2.2.2.3.  Sampling procedure  
Sampling locations 
Although the 2011 report does not provide background information on maize MON 810 adoption rate 
in various EU countries, the applicant claims that the sampling focuses on areas with high uptake of 
maize  MON  810.  The  applicant  also  indicates  that  an  area  to  be  considered  for  sampling  is  a 
´geographical zone where maize is typically grown under similar agronomic practices isolated from 
other maize by barriers that may impair an easy exchange of target pests between the areas, e.g., Ebro 
valley´. Considering areas as large as north-east Iberia, the current sampling protocol proposed by the 
applicant  pools  together  samples  from  three  fields  separated  by  distances  of  over  50  km  and 
recommends not to sample within the same location sites over time. The EFSA GMO Panel is of the 
opinion that, while this protocol might be appropriate to set up a baseline for regional susceptibility, it 
is not suitable for resistance monitoring over time and an early detection of resistance evolution. In the 
framework of CSM, the purpose is to check the assumption of the environmental risk assessment 
(ERA), i.e. that the high-dose/refuge strategy maintains the susceptibility of target pests.  
Overall, the sampling efforts should be mainly concentrated on areas
14 where there is high uptake of 
maize MON 810 associated with high target pest infestation (i.e. more than one generat ion of the 
target pests per year). Because of the high selection pressure in these areas (e.g. the Ebro Valley), this 
is where resistance evolution in target pests is more likely to occur. However, the EFSA GMO Panel 
acknowledges that a large variability of maize  MON 810  uptake might exist within  such an area. 
Indeed, although the overall uptake may remain low  to moderate in that area, there could be several 
agricultural ´zones´ within the area where the maize MON 810 uptake already reaches 80 %. These 
´zones´ should be sampled to determine whether or not the high-dose/refuge strategy as implemented 
prevents resistance evolution.  
The EFSA GMO Panel therefore recommends that the applicant screens the ´areas´ of high selection 
pressure and selects geographical ´zones´ of a smaller scale (i.e.  county) within the broader area. 
These smaller geographical zones should be monitored over time.  Early detection  of resitance 
evolution in such zones would give more time to  growers for implementing  appropriate mitigation 
measures and would delay resistance evolution on a larger scale. 
The EFSA GMO Panel does not recommend sampl ing all relevant  ´zones´, as defined above, but 
advises the applicant to sample a minimum of three zones of high uptake of maize MON 810 within a 
given larger area (i.e. the Ebro Valley). This would be considered sufficiently representative of a target 
pest population occupying a large area. At the time of adoption of this opinion, maize MON 810 is the 
only Cry1-expressing maize cultivated in the EU. However, the EFSA GMO Panel recommends that 
in future the applicant takes into consideration the overall uptake of Cry1 -expressing maize when 
identifying zones of high adoption for sampling target pests. 
 
 
                                                       
14 That is ´province´ in Spain, ´region´ in France or even ´lander´ in Germany. Scientific Opinion on 2011 Monsanto PMEM report on GM maize MON 810  
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Sampling frequency 
As part of the IRM plan, the applicant
15 proposed to sample multi-voltine ECB and MCB populations 
every two years in areas where maize  MON 810 adoption rate varies between 20 % and 80 % of the 
total arable land.  Annual sampling is foreseen  only in exceptional circumstances in areas of high 
uptake (i.e. > 80 %; where non-Bt refugia are not implemented).  
Based on the outcomes of the additional  simulations with the Alstad and Andow (1995) model (see 
Appendix A), and considering that resistance evolution should focus on areas of high adopti on rates, 
the EFSA GMO Panel recommends annual sampling. The Panel‟s recommendations are summarised 
in Table 1.  
Table 1:   Recommended sampling frequency of target pests 
Maize MON 810 uptake
16 
in a zone 
(% total arable land) 
Sampling frequency 
For a monovoltine target 
pest population 
For a bi-/multi-voltine target 
pest population 
< 20 %  None  None 
20 % to < 50 %  
(R allele frequency of 3 %) 
Biennial  Biennial 
50-80 % (R allele frequency of 1 %)  Biennial  Annual 
> 80 %
17  Annual 
 
 
Further considerations for sampling frame 
In its opinions on previous reports (EFSA GMO Panel, 2011b, 2012a), the EFSA GMO Panel advised 
the applicant ´to include in the sampling surviving target lepidopteran pests within maize MON 810 
fields in order to detect potentially resistant individuals. The sampling should be mainly done as late 
as  possible  in  the  growing  season  in  order  to  increase  the  likelihood  of  detecting  surviving 
individuals´.  
During its assessment of the present report, the EFSA GMO Panel considered the concerns raised by 
the applicant as well as the limitations of the suggested approach.  
The rationale for monitoring Bt-fields is that the increase in allele frequencies in Bt-stands, should it 
appear,  is  expected  to  be  faster  and  surviving  individuals  might  be  an  indication  of  resistance 
evolution. However, there is the probability to sample individuals on ´outlier´ plants not expressing the 
insecticidal toxin and hence not linked with resistance evolution.  
Therefore,  aiming  to  achieve  early  detection  of  resistance  evolution,  the  EFSA  GMO  Panel 
recommends: 
-  whenever possible, to sample ´mixed´ populations, namely from plants in refugia and from Bt-
maize fields; and 
-  to make the best use of the farmer questionnaire to report any unusual presence of damaged 
maize plants and of surviving target pests in maize MON 810 fields (see sections 3.2.1 and 
3.3).  
                                                       
15 See Section „Documentation provided to EFSA‟ 
16 At the time of adoption of this opinion, maize MON 810 is the only Cry1-expressing maize cultivated in the EU. However, 
the EFSA GMO Panel recommends that in future the applicant takes into consideration the overall uptake of Cry1-expressing 
maize when identifying zones of high adoption for sampling target pests. 
17 In some regions where farmers do not comply with non-Bt refugia implementation (see section 2.2.1.2). Scientific Opinion on 2011 Monsanto PMEM report on GM maize MON 810  
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2.2.3.  Communication with and education of farmers 
From the ANTAMA survey
18 in the Ebro valley in Spain, where most of the maize MON 810 was 
grown in 2011, all the farmers planting maize MON 810 were aware of the recommendation to plant a 
non-Bt refuge. Of the surveyed farmers, 89 % considered that they were well informed about refugia 
implementation and 11 % ´somehow informed´. 
As described in section 2.2.1.2 above, the EFSA GMO Panel still noted that a certain percentage of 
farmers growing maize MON 810 did not comply with the implementation of non-Bt refugia in 2011. 
However, the EFSA GMO Panel acknowledges the initiatives taken by the applicant over the last few 
years to improve the education of farmers (i.e. by means of farmer interviews on refugia compliance in 
local newspapers and by revising the user‟s manual of the farmer questionnaire). This is supported by 
the improvement in the percentage of farmers complying with the refugia implementation over the 
years (i.e. 81 % in 2009, 88 % in 2010, 93 % in 2011).  
The EFSA GMO Panel remains of the opinion that special attention should be paid (1) to refugia 
implementation in those areas in which the likelihood of resistance evolution is higher as well as to (2) 
the implementation of appropriate IPM measures against relevant regionally occurring pests before the 
onset of resistance.  
2.3.  Conclusions and recommendations on CSM 
The EFSA GMO Panel assessed the CSM/IRM plan in 2011 and its implementation. First of all, the 
EFSA GMO Panel identifies similar shortcomings in the methodology as it did in the 2009 and 2010 
reports and hence reiterates its previous recommendations to the applicant for improvement of the 
methodology (for further details, see section 2.3 of EFSA GMO Panel, 2011b, 2012a). 
Secondly,  the  EFSA  GMO  Panel  considered  the  concerns  expressed  by  the  applicant  and  hence 
advises the applicant to take the following points into consideration when reviewing its IRM plan and 
in particular the resistance monitoring of target pests: 
-  to revise the monitoring protocol, aiming to detect a resistance allele frequency between 1 % 
(for a high maize MON 810 adoption rate) and 3 % (for low to moderate adoption rate); 
-  to focus the sampling of target lepidopteran pests in geographical zones (i.e. counties) within a 
larger  area  where  the  likelihood  of  resistance  evolution  is  the  greatest.  These  zones  are 
characterised by a high maize MON 810 uptake and multivoltine target pest populations;  
-  whenever possible, to sample pest larvae from mixed batches within non-Bt refugia and Bt-
plants on GM maize;  
-  to sample on a annual basis for high maize MON 810 uptake (see Table 1). 
The  EFSA  GMO  Panel  reiterates  its  previous  recommendation  to  ´consider  regionally  important 
lepidopteran pests (other than ECB and MCB) of maize MON 810 in the context of CSM for IRM 
strategy´. However, the EFSA GMO Panel suggests that the applicant uses farmer questionnaires as a 
tool to give early-warning of the potential for resistance evolution in populations of these non-target 
pests by reporting observations on the occurrence and unexpected survival (and possible damage) of 
their larvae on Bt-maize plants. In the event that farmers report indications of possible resistance 
evolution in these regionally occurring non-target lepidopteran pests, they should be considered for 
inclusion in the routine IRM plan. 
                                                       
18 MON 810 2011 PMEM report, Section 3.2.1.1 Scientific Opinion on 2011 Monsanto PMEM report on GM maize MON 810  
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Finally, the EFSA GMO Panel concludes that the available dataset does not show evidence of change 
in susceptibility in the target pests. Moreover, the EFSA GMO Panel is not aware of any scientific 
report on field resistance in target pests detected in the EU so far. Nevertheless, the local adoption rate 
can be high in some regions and the EFSA GMO Panel advises the applicant to adapt the monitoring 
of the resistance allele frequency in order to ensure the early detection of resistance evolution. To 
conclude, the applicant did not provide new data from the 2011 growing season of maize MON 810 
that would invalidate previous evaluations by the EFSA GMO Panel of maize MON 810 (EFSA GMO 
Panel, 2009, 2011b, 2012a,b,c).  
3.  General Surveillance (GS) 
3.1.  Summary of the information provided by the applicant 
As for the previous growing seasons, the 2011 plan for GS
19 of maize MON 810 consisted of four 
elements: (1) a  farmers‟ survey; (2) a search for relevant publications related to maize MON 810 
and/or the Cry1Ab protein; (3) company stewardship activities; and (4) alerts on environmental issues 
by the authorities and existing networks. 
Novel datasets specific to the 2011 growing season are:  
(1)  The survey based on 249 questionnaires received from farmers in six European countries (i.e. 
29 in the Czech Republic, 10 in Poland, 150 in Spain, 42 in Portugal, 15 in Romania and 3 in 
Slovakia). According to the applicant, the farmers/fields were selected among the countries 
depending on the level of market penetration of maize MON 810, the method of selection 
depended upon the availability of a sampling frame for that country. The farmer surveys were 
carried  out  by  third  parties  with  experience  of  conducting  agricultural  surveys,  with  the 
exception  of  Romania,  where  Monsanto  representatives  assisted  the  farmers  to  fill  in  the 
questionnaire.
20 In its report, the applicant concluded that the  2011 statistical analysis of the 
249 questionnaires did not reveal any unanticipated adverse effects that could be associated 
with maize MON 810. 
(2)  A list of peer-reviewed publications on the safety of maize MON 810 and/or the Cry1Ab 
protein  published  between  June  2011  and  beginning  of  June  2012  was  submitted.  The 
applicant used specific key words and searched in journals included in the Web of Science 
database.
21 The first set of papers resulting from the search was screened for relevance to the 
ERA of maize MON 810. The applicant reported 12 publications on molecular and food/feed 
aspects, 10 publications related to the ERA of maize MON 810 and 10 review papers on Bt-
maize. The applicant concluded that the peer -reviewed literature did  not raise any safety 
concerns for maize MON 810. 
The applicant did not provide details on existing monitoring networks likely to be of use for GS of 
maize MON 810. Reference was made to the ongoing project by a Europabio Working Group to map 
the existing European networks and to set up a unique reporting system.
22 
3.2.  Assessment by the EFSA GMO Panel 
3.2.1.  Farmer questionnaires 
The EFSA GMO Panel, in close collaboration with the EFSA Unit for Scientific Assessment Support 
(EFSA  SAS  Unit),  assessed  the  methodology  followed  by  the  applicant  to  analyse  the  farmer 
                                                       
19 The 2010 MON 810 report submitted by Monsanto is publicly available on the webpage of the EC Directorate General for 
Health and Consumers, at http://ec.europa.eu/food/plant/gmo/reports_studies/report_2011_mon_810_en.htm  
20 MON 810 2011 PMEM report, Appendix 1. 
21 MON 810 2011 PMEM report, section 3.1.6. 
22 MON 810 2011 PMEM report, section 3.1.2.3. Scientific Opinion on 2011 Monsanto PMEM report on GM maize MON 810  
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questionnaires.  Appendix  B  provides  methodological  guidance  for  a  systematic  evaluation  of  the 
farmer questionnaires, including a list of evaluation criteria (e.g. sample size, survey response rate, 
statistical analysis) for the farmer questionnaires and the statistical analysis. 
The evaluation of the overall farmers survey (including, for example, sampling of farmers, types of 
questions, method of conduct interviews, data validation, method used for the design of the statistical 
analysis) is given in Appendix B. Similar weaknesses in the methodology as in previous reports were 
identified. In addition, the 2011 report provides limited information on the sampling methodology, and 
the possibility of selection bias in the survey cannot be ruled out. 
Recommendations to the applicant for the improvement of the methodology are listed in section 3.3 
and in Appendix B. However, from the analysis of the 2011 farmer questionnaires on maize MON 
810, the EFSA GMO Panel concludes that no unanticipated adverse effects can be identified.  
3.2.2.  Existing monitoring networks 
The applicant referred to the ongoing project by a Europabio Working Group to map the existing 
European networks and did not deliver information on possible existing monitoring networks that 
could be involved in the GS of maize MON 810. Therefore, the EFSA GMO Panel acknowledges the 
same lack of relevant information that was identified in the previous reports. The EFSA GMO Panel is 
of the opinion that, in addition to farmer questionnaires, existing surveillance networks provide an 
additional tool for GS of GM plants that complement the farmer questionnaires. In this respect, the 
applicant should, where appropriate, use existing monitoring networks in its PMEM plan, as they are 
likely to collect relevant data for the GS of maize MON 810 (see EFSA GMO Panel, 2011a, for 
further guidance). 
3.2.3.  Literature review 
The EFSA GMO Panel acknowledges that the papers related to maize MON 810 and/or the Cry1Ab 
protein  selected  by  the  applicant  (published  between  June  2011  and  beginning  June  2012)  were 
adequately discussed and put into the context of the overall safety assessment of maize MON 810.  
With the exception of three papers (i.e. Peterson et al., 2011; Rossi et al., 2011; Bell et al., 2012), most 
had already been addressed by the EFSA GMO Panel in its scientific opinions on maize MON 810 or 
on Bt-maize (for further details, see EFSA GMO Panel, 2011b, 2012a,b, 2013). The three papers 
mentioned previously were reviewed by the EFSA GMO Panel and no safety concerns owing to maize 
MON 810 were identified. Therefore, none of the selected papers relating to maize MON 810 and/or 
the Cry1Ab protein (published between June 2011 and beginning June 2012) report adverse effects on 
human and animal health or the environment.  
However, the EFSA GMO Panel notes that one relevant paper related to Bt-maize/maize MON 810 
and/or the Cry1Ab protein was not reported by the applicant (i.e. Székács et al., 2012). The paper by 
Székács et al. (2012) was discussed by the EFSA GMO Panel in its scientific opinion updating the risk 
assessment conclusions and risk management recommendations on  maize MON 810 (EFSA GMO 
Panel, 2012c). In that scientific opinion, the EFSA GMO Panel concluded that ´results reported by 
Székács et al. (2012) did not contain new information that would invalidate the previous conclusions 
on the molecular characterisation of maize MON 810 made by the EFSA GMO Panel´.  
Therefore, the outcome of the literature review confirms the previous conclusions on the safety of 
maize MON 810 made by the EFSA GMO Panel. Therefore, the EFSA GMO Panel considers that its 
previous conclusions on maize MON 810 remain valid and applicable (EFSA GMO Panel, 2009, 
2011b, 2012a,b,c). Scientific Opinion on 2011 Monsanto PMEM report on GM maize MON 810  
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3.3.  Conclusions and recommendations on GS 
From the data provided by the 2011 farmer survey on maize MON 810 and the literature review, no 
adverse effect of the cultivation of maize MON 810 in 2011 on human and animal health or the 
environment can be identified.  
However, the EFSA GMO Panel identified shortcomings similar to those found in the methodology 
used for previous reports and therefore reiterates similar recommendations to the applicant (for further 
details on the recommendations, see Appendix B).  
In addition, considering novel datasets specific to the 2011 growing season of maize MON 810, the 
EFSA GMO Panel highlights the following recommendations: 
-  The sampling frame should be representative of the target population and described in the 
report.  A  description  of  the  method  to  ensure  that  units  are  randomly  selected  from  the 
sampling  frame  should  be  included  in  the  report,  including  where  relevant  the  statistical 
software  and/or  the  program  code  used  for  this  procedure.  This  method  should  be  used 
consistently in all regions sampled and in all years of the survey. Moreover, the losses to 
sampling  should  be  fully documented, i.e.  the  number  of  farmers  not  participating  in  the 
survey and their reasons should be documented. 
-  It would be preferable if the standardised interviews are carried out by independent parties to 
reduce interviewer bias.  
-  The choice of statistical test should be based on the number of possible categories. Analysing 
multinomial data as a series of binomial proportions increases the experiment-wise type I error 
rate and therefore it is recommended to use a multinomial analysis to test for the distributional 
difference  with  a  subsequent  binomial  approach  used  to  test  for  differences  in  a  specific 
category or to correct for the multiplicity of testing. 
-  Data should be pooled and statistically analysed with all available data (i.e. to increase power) 
over years. At the end of the 10 years of GS, the applicant should conduct a statistical analysis 
with all pooled data. 
-  A codification for farmers surveyed repeatedly over the years should be set up.  
In its scientific opinions on previous reports (EFSA GMO Panel, 2011b, 2012a), the EFSA GMO 
Panel already suggested that the applicant uses the farmer questionnaire in order to collect data on 
additional parameters (e.g. the occurrence of regionally occurring non-target lepidopteran pests). In 
the Panel‟s view, the farmer questionnaire could also be used as a complementary tool for an early 
detection of resistance evolution in target pests (e.g. from observations of the unusual presence of 
damaged Bt-maize plants or of surviving target pests in the Bt-maize field). 
Furthermore, in order to improve the sampling frame of the farmers survey, the EFSA GMO Panel 
reiterates the importance of national GMO cultivation registers, as referred to in Article 31.3 (b) of 
Directive 2001/18/EC (EC, 2001); and its recommendations to applicants to consider how they may 
make  best  use  of  the  information  recorded  in  national  registers  and  opens  dialogue  with  those 
responsible for the administration of these registers where maize MON 810 is cultivated. 
The outcome of the literature review confirms the previous conclusions on the safety of maize MON 
810 made by the EFSA GMO Panel.  
To conclude, the applicant did not provide new data from the GS of maize MON 810 grown in 2011 
that would invalidate previous EFSA GMO Panel evaluations of maize MON 810 (EFSA GMO Panel, 
2009, 2011b, 2012a,b,c).  Scientific Opinion on 2011 Monsanto PMEM report on GM maize MON 810  
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OVERALL CONCLUSIONS AND RECOMMENDATIONS 
The data submitted by the applicant in its 2011 MON 810 report does not indicate any adverse effects 
on human and animal health or the environment arising from maize MON 810 cultivation in 2011. 
Considering the weaknesses in the methodology, similar to those identified in previous reports, the 
EFSA GMO Panel reiterates the general recommendations given in its scientific opinion providing 
guidance  on  PMEM  of  GM  plants  (EFSA  GMO  Panel,  2011a)  and  the  additional  specific 
recommendations for the improvement of the PMEM methodology of maize MON 810 (EFSA GMO 
Panel, 2011b, 2012a). 
Considering  the  comments  raised  by  the  applicant,  the  EFSA  GMO  Panel  makes  further 
recommendations for the improvement of the methodological approach to the resistance monitoring of 
target pests (e.g. sampling strategy of target pests and detection method aiming at the detection of 
resistance evolution at an early stage). However, the EFSA GMO Panel remains of the opinion that the 
possible resistance evolution is not an environmental concern per se but may lead to altered pest 
control practices that may cause adverse environmental effects. Furthermore, the EFSA GMO Panel is 
not aware of any scientific report on field resistance in target pests detected in the EU so far. 
Therefore, the EFSA GMO Panel is of the opinion that the outcomes of the 2011 MON 810 report do 
not  invalidate  the  Panel‟s  previous  scientific  opinions  on  maize  MON  810  and  its  subsequent 
recommendations on risk management and monitoring. 
DOCUMENTATION PROVIDED TO EFSA 
1.  Letter  from  the  European  Commission,  dated  7  May  2013,  to  the  EFSA  Executive  Director 
requesting the assessment of the MON 810 monitoring report for the 2011 cultivation season 
provided by Monsanto, and its annex. 
2.  Letter
23 from Monsanto, dated 14 December 2012, to the European Commission. 
3.  Acknowledgement letter, dated 17 June 2013, from the EFSA Executive Director to the European 
Commission. 
4.  Letter, dated 6 November 2013, from the EFSA Executive Director to the European Commission. 
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APPENDIX  A  –  SIMULATION  EXERCISE  TO  OPTIMIZE  CSM  FOR  INSECT  RESISTANCE 
MANAGEMENT  
In its previous scientific opinions on annual reports on maize MON 810, the EFSA GMO Panel has 
discussed the likelihood of insurgence of resistance by the target organisms to maize MON 810 and 
advised on possible CSM plans (EFSA GMO Panel, 2011b, 2012a). 
The IRM plan provided by the applicant aims at early detections of the possible onset of resistance in 
target organisms where maize MON 810 is cultivated. Several features linked to the biology of the 
target organism and the receiving environment, in particular the location and size of refuges where the 
Bt-crop is to be released, are the major drivers for such trends in allele frequency under a given set of 
conditions.  
Based on the first set of simulations (EFSA GMO Panel, 2012a), the EFSA GMO Panel argued that 
the threshold of 5 % allele presence detection proposed by the applicant and the biennial sampling 
plan would not be sufficient in many cases to detect sufficiently early the onset of resistance and 
consequently the early implementation of contingency plans.  
As a consequence of the comments provided by the applicant to the European Commission,
24 the 
EFSA GMO Panel conducted further simulations with the aim of giving more detailed indications on 
CSM plans and also provided support on the effectiveness of possible mitigation measures. 
The additional simulations aimed at estimating, under different maize  MON 810 uptake
25 scenarios, 
the number of generations required to reach an allele frequency of 0.5 in the target insect population, 
once the resistance allele frequency detected during CSM had reached 1, 3 or 5 %. New simulations 
were run using the model by  Alstad and Andow (1995) with the shareware software  Populus.
26 In 
particular, the model was run using the parameters‟ values listed in Table 2. 
Table 2:   Parameters‟ values used for the model 
Parameters  ECB 
Adoption rate of Bt- maize  Ranging from 20 to 90 % 
Initial allele frequencies  0.006 (estimated baseline for ECB) 
Fecundity  100 
Dominance  0.01 (Almost fully recessive) 
Preference  for  Bt-maize  in 
second generation  120 % 
Overwinter survival  0.01 
Survival  of  susceptible 
homozygotes on Bt  0.001 
The starting population is supposed to be equally abundant in Bt-stands and refugia in the first year of 
Bt-maize release. All other parameters were set to default values in the software.  
Results 
In the following Table 3, an overview of the results for bivoltine populations is presented. The allele 
frequency  of  the  population  over  time  (for  each  generation)  is  indicated  in  the  case  of  different 
adoption rates of maize MON 810. The occurrence of field-detected resistance is conventionally set at 
                                                       
24 See Section „Documentation provided to EFSA‟ 
25 At the time of adoption of this opinion, maize MON 810 is the sole Cry1-expressing maize cultivated in the EU. However, 
the EFSA GMO Panel recommends that in future the applicant takes into consideration the overall uptake of Cry1 -
expressing maize when identifying zones of high adoption for sampling target pests. 
26 Populus, Vers. 5.4. Copyright © 2007 D. N. Alstad, University of Minnesota, http://wwumnw.cbs.edu/populus Scientific Opinion on 2011 Monsanto PMEM report on GM maize MON 810  
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an allele frequency of 0.5 in the population. The model was initiated simulating an allele frequency of 
0.006 in the original population as recorded in population of ECB in Italy and Slovakia (Engels et al., 
2010). 
Table 3:   Overview of model result for bivoltine pest populations 
Generations  20 %  40 %  50%  60 %  70 %  80 %  90 %   
1    0,006  0,006  0,006  0,006  0,006  0,006  0,006   
2    0,0061  0,0062   0,0064  0,0066  0,0071  0,0077  0,0093 
3    0,0069  0,0084  0,0095  0,0110  0,0131  0,0167  0,0271 
4    0,0070  0,0088  0,0101  0,0119  0,0146  0,0197  0,0380 
5    0,0083  0,0123  0,0154  0,0200  0,0271  0,0417  0,1072 
6    0,0084  0,0129  0,0166  0,0223  0,0317  0,0541  0,2074 
7    0,0101  0,0190  0,0276  0,0430  0,0724  0,1565  0,6771 
8    0,0103  0,0203  0,0308  0,0516  0,0990  0,2783  0,9317 
9    0,0125  0,0324  0,0592  0,1251  0,2927  0,6838  0,9904 
10    0,0128  0,0357  0,0714  0,1817  0,5014  0,8982  0,9985 
11    0,0158  0,0637  0,1610  0,4225  0,7856  0,9747  0,9998 
12    0,0163  0,0748  0,2284  0,6288  0,9167  0,9935  1 
13    0,0205  0,1464  0,4307  0,8186  0,9716  0,9985  1 
14    0,0213  0,1919  0,5957  0,9143  0,9900  0,9996  1 
15    0,0276  0,3346  0,7603  0,9629  0,9967  0,9999  1 
16    0,0288  0,4502  0,8607  0,9836  0,9989  1  1 
17    0,0389  0,6050  0,9250  0,9931  0,9996  1  1 
18    0,0409  0,7190  0,9591  0,9970  0,9999  1  1 
19    0,0569  0,8155  0,9786  0,9987  1  1   
20    0,0613  0,8786  0,9886  0,9994  1  1   
21    0,0878  0,9236  0,9941  0,9998  1  1   
22    0,0969  0,9513  0,9968  0,9999  1  1   
23    0,1377  0,9699  0,9984  1  1  1   
24    0,1575  0,9810  0,9991  1  1  1   
25    0,2146  0,9883  0,9996  1  1  1   
26    0,2505  0,9927  0,9998  1  1  1   
27    0,3203  0,9955  0,9999  1  1  1   
28    0,3720  0,9972  0,9999  1  1  1   
29    0,4461  0,9983  1  1  1  1   
30    0,5051  1  1  1  1  1     
 
The figures in boxes indicate after how many generations the population allele frequency reaches a 
level > 0.5 and it is therefore considered resistant. The figures in bold, in bold and in italic, and 
underlined indicate the generation in which the sensitivity chosen for the sampling plan (respectively 
at 0.01, 0.03 and 0.05 %) would allow the detection of an increase in allele frequency. The closer these 
dates are to the generation in which the allele frequency has reached the 0.5 value, the shorter is the 
time available to react with a remediation plan. 
In case of a biennial sampling programme, the effectiveness of the monitoring plan in preventing the 
onset of resistance is affected by the fact that information on allele frequency may be available only 
the year after the limit has in fact been reached (i.e. the data in the second next row, in the case of a 
bivoltine population).  
It is reasonable to consider that a minimum of 1 year-delay from detection of resistance and taking an 
adaptive response is required (Andow and Ives, 2002). However, it has to be considered that it may be 
necessary to wait for a few months in order to obtain the results from the laboratory tests with the ECB 
individuals collected from the field. Therefore it seems a safe estimate to consider that to implement 
any mitigation measures in fields, it is necessary that in the two following growing seasons (i.e. three 
to four generations in the case of a bivoltine population of ECB) the allele frequency of 0.5 is not 
reached. Scientific Opinion on 2011 Monsanto PMEM report on GM maize MON 810  
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From the results presented in Table 3, it is also possible to evaluate the efficiency of the reduction of 
the percentage of areas cropped with maize MON 810 once signs of increasing allele frequency are 
detected. When a given allele frequency indicated in the table is detected, the efficiency of such a 
reduction can be assessed by looking in the respective column to see how many generations will then 
be needed before resistance is achieved with a reduced level of adoption of maize MON 810. 
For example with an adoption of maize MON 810 of 60 % of the total cropped area, when a 0.05 allele 
frequency is detected, the population is expected to become resistant two years later (four generations, 
see column 5). However, if a reduction to 20% of the maize MON 810 cropped area is immediately 
implemented, maize MON 810 is expected to maintain its effectiveness for five-six more years (see 
column 2 in Table 3). This is only valid if annual sampling is carried out and if action is taken before 
the following growing season. In the case of biennial samplings, as currently implemented, the allele 
frequency might already be higher than 0.05 when detected. Using the same example, if in year n, the 
allele frequency is 0.0430 (generation 7 of column 5), it won‟t be picked up by a sampling procedure 
aiming to detect 0.05 and the next sampling will occur two years after when the allele frequency will 
have reached 0.1817, far too late to undertake any efficient measures.  
According to the results of the model, in the case of a very sensitive annual sampling plan aimed at 
detecting an occurrence of 0.01 allele frequency in the population of the target insect, even at high 
adoption rates (80 %), there is time enough to implement contingency plans before resistance occurs in 
field. However, in the case of very high adoption rates, a drastic reduction in maize MON 810 is 
needed to significantly delay insect resistance (see Table 1).  
When a detection limit of 0.05 is set, it appears that a successful contingency plan can be efficiently 
applied only for annual samplings and in the case of low to medium adoption rates up to 50 %. A 
detection limit of an allele frequency of 0.03 increases the time available to react for low and medium 
rates of adoption.  
These  predictions  are  based  on  hypothetical  samplings  done  in  the  refuge  areas  (as  currently 
conducted by the applicant), while the increase in allele frequencies in Bt-stands, should this appear, is 
expected to be faster. For instance, according to the model in the case of ECB surviving in Bt-stands, 
the detection of 5 % will only leave one additional generation before resistance is achieved in Bt-
fields. 
When considering the possibility of implementing biennial sampling plans, the results indicate that the 
detection of a 0.05 allele frequency can be applied only for low adoption rate up to 40 %. Even the 
0.03 detection limit can be applied only if the adoption rate does not exceeds 40 %. Over 40 %, a 
biennial sampling plan is acceptable only when a detection limit of an allele frequency of 0.01 is the 
aim and for an adoption rate of maize MON 810 up to 50 %. 
Discussion 
The early detection of an increased allele frequency in the population of the target pest is the main 
goal of a IRM plan. IRM is a proactive measure necessary to ensure the effectiveness of this measure 
in preventing a possible adaptation (see EFSA GMO Panel, 2011). The agronomic consequence of the 
onset of resistance in a pest population is assumed to be a population level of 70-80 % of pre-control 
densities one year after resistance allele frequency reaches 0.5 (Comins, 1977; Alstad and Andow, 
1995).  
Based on our simulation exercise, the EFSA GMO Panel estimates that a level of detection of an allele 
frequency of 0.05 does not allow the necessary time for taking any adaptive response for bivoltine 
strains of ECB. These results are in agreement with Andow and Ives (2002) who considered the case 
of ECB in the USA. 
The sampling strategy (frequency and threshold) should be adapted to the potential selection pressure, 
i.e., maize MON 810 uptake. In addition to the selection of the appropriate detection threshold, the 
sampling procedure should ensure enough statistical precision. Indeed, a given allele frequency level 
which has been reached in a region might not be detected in due time because of the sampling errors.   Scientific Opinion on 2011 Monsanto PMEM report on GM maize MON 810  
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Therefore, the EFSA GMO Panel suggests that, an efficient monitoring program should be based on 
annual samplings and aimed at detecting allele frequency below 0.03 with enough confidence  for 
adoptions rates of maize MON 810 lower than 50 %. In case of higher adoption rates a detection limit 
of 0.01 is deemed necessary. 
In case of monovoltine ECB populations, the available time to react is longer and therefore monitoring 
programs can be revised accordingly.  
For monitoring plans with Sesamia spp., the possible occurrence of multivoltine populations of this 
species makes the necessity of annual sampling plans even more stringent. 
   Scientific Opinion on 2011 Monsanto PMEM report on GM maize MON 810  
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APPENDIX B – SAS TECHNICAL REPORT ON THE EVALUATION OF FARMER QUESTIONNAIRES  
BACKGROUND 
This  Appendix  B  was  prepared  by  the  EFSA  SAS Unit  to  support  the  EFSA  GMO  Panel in its 
evaluation of the monitoring report on maize MON 810 for the 2011 growing season, specifically to 
provide methodological guidance on evaluation of the farmer questionnaires submitted as part of the 
GS programme, which aimed to identify adverse affects of the GM maize or its use on human and 
animal health or the environment that had not been anticipated in the ERA. 
METHOD 
Evaluation criteria were developed based on the principles of design for cross-sectional studies, and in 
particular surveys. The evaluation grid can be applied to surveys used for GS of GM plants. In July 
2011, the EFSA GMO Panel updated its guidance on the PMEM of GM plants (EFSA GMO Panel, 
2011a).  The  criteria  reflect  the  recommendations  in  this  guidance  document.  These  criteria  were 
previously applied in the assessment of the 2009 - 2010 MON 810 monitoring reports and the 2010 – 
2011 Amflora monitoring reports (EFSA GMO Panel, 2011b, 2012 a,d,e). 
Study design principle  Criteria 
Sampling frame  1)  The sampling frame used is specified 
2)  The  total  population  included  the  sampling  frame  is 
specified 
3)  The  characteristics  of  the  population  included  in  the 
sampling  frame  are  described,  including  region, 
agricultural practices, GM cultivation 
4)  The sampling  frame coverage is appropriate for GM 
cultivation in the EU 
Sampling  method  (sample 
bias) 
1)  The sampling method to select sample units from the 
sampling frame is described 
2)  The  sampling  method  ensures  sampling  units  from 
representative  environments,  reflecting  the  range  and 
distribution  of  plant  production  systems  and 
environments  exposed  to  the  GM  plants  and  its 
cultivation are sampled 
3)  A list of sample units selected from the sample frame is 
provided 
4)  The sampling method minimises selection bias 
Sample  size  (sample 
precision) 
1)  The  size  of  the  adverse  effect  to  be  measured  is 
specified  and  scientifically  justified  and  is  within  an 
acceptable limit of change. 
2)  The significance level is specified and the chosen level 
is scientifically justified (Type I error rate) 
3)  The  power  is  specified  and  the  chosen  level  is 
scientifically justified (Type II error rate) 
4)  A  literature  reference  for  the  sample  size  method  is 
provided 
5)  The sample size calculation method is appropriate for a 
proportion in a cross-sectional study 
6)  The sample size is sufficient to detect an adverse effect 
related to GM cultivation 
 
Survey  response  rate  (non 
response bias) 
1)  Follow-up method for non-responders is described and 
appropriate 
2)  Response rate is specified 
3)  Details of losses in sampling are described 
4)  he  number of partial responses and reasons for  non-
completion are specified Scientific Opinion on 2011 Monsanto PMEM report on GM maize MON 810  
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5)  omparison  is  made  between  characteristics  of 
responder group and non-responder group 
6)  Comparison  is  made  between  characteristics  of 
responder  group    and  independent  sources  of 
information about the target population 
7)  The effects of non response bias have been minimised 
 
Instrument design  1)  The  study  design  includes  considerations  to  avoid 
interviewer bias 
2)  Where interviewers are used the interviewer training is 
described 
3)  The  selection  of  open  and  closed  questions  is 
appropriate for the question type 
4)  The  questions  are  clearly  phrased  and  not  open  to 
misinterpretation 
5)  The  questions  encourage  independent  and  objective 
responses 
6)  The  comparator  used  in  the  study  is  described  and 
appropriate for general surveillance 
7)  The  instrument  has  been  previously  tested  and 
validated 
Instrument validity  1)  Content  validity  –  the  survey  includes  questions 
relevant to assess 
•  Background data 
Identifier  of  location  of  monitoring  site  and  comparator  site, 
surrounding  landscape,  type  of  field  margins,  proximity  to 
conservation areas, cultivation and management of the GM field 
including  recent  history  and  previous  cropping,  soil  (type, 
structure, quality), nutrient status, fertilization, irrigation. 
•  Data informing on possible change in behaviour and 
performance of GMP 
Other GMPs cultivated, number of years of cultivation of GMP, 
cultivation and tillage from the removal of the previous crop to 
seed  sowing,  crop  husbandry  including  sowing/planting  date, 
post  planting  management,  crop  emergence,  growth  (vigour, 
height),  pest,  disease  and  weed  management,  flowering, 
standing  ability,  harvesting  date  and  methods,  yield,  post-
harvest management and subsequent cropping of the site, post-
harvest storage, handling, processing, feeding 
•  Data  informing  on  possible  ecological/environmental 
impacts  of  GMP  on  the  protection  goals  and 
measurement 
Weed  and  pest  populations,  observations  of  other  flora  and 
fauna  such  as  insects,  birds  and  mammals,  pollination  and 
presence of pollinators, health of humans and performance of 
livestock. 
•  Implementation of specific management requirements 
Implementation  of  risk  management  measures,  coexistence 
segregation  measures,  stewardship  recommendations,  specific 
management due to regional environmental requirements 
2)  Criterion validity – agronomy parameters reported in 
the survey are compared with field trial data to test for 
concurrency 
3)  External  consistency  -  results  from  survey  are 
compared  to  and  conform  with  independent  external 
data  sources  (for  example  pest/weed  occurrence 
reports,  soil  characteristics  from  geological  surveys, 
authorisations  and  use  reports  for  plant  protection 
products) Scientific Opinion on 2011 Monsanto PMEM report on GM maize MON 810  
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4)  Plausibility  of  responses  –  results  for  cultivation 
methods,  agronomy  parameters  and  weed/pest 
management practices reported in the survey conform 
to European agricultural practices 
5)  Construct  validity  –  consistency  and  agreement 
between outcome variables is examined 
Data validation  1)  Data validation procedure are documented 
2)  Results  excluded  from  the  statistical  analysis  during 
validation are reported 
3)  Missing values are reported 
 
Longitudinal aspects  Comparison with survey results from previous years 
1)  The survey is applied to the sample unit for multiple 
years in order to assess residual effects 
 
Statistical analysis  1)  Objective and hypotheses for analysis are clearly stated 
2)  A statistical analysis plan is provided 
3)  Statistical  analysis  includes  analysis  of  pre-defined 
sub-groups according to PMEM guidance e.g country 
4)  Statistical analysis is appropriate for the data types 
5)  Results are clearly and consistently presented 
6)  The report should include descriptive statistics for the 
outcome variables 
7)  The issue of multiplicity is addressed 
8)  Method for handing missing values are described 
9)  Where  appropriate  confidence  intervals  should  be 
provided 
10) The results of post-hoc analysis should be identifiable 
Report conclusions  1)  The report conclusions are clearly stated 
2)  The  study  design  is  appropriate  to  assess  the 
conclusions 
3)  The data presented supports the conclusions presented 
in the report 
Results 
Sampling frame 
1)  Sampling frame specification 
Appendix 1 of the 2011 MON 810 report specifies that in Portugal and Romania the sampling frame 
for the survey was a public register. In Czech Republic, Slovakia and Poland, customer lists obtained 
from companies selling seeds were used. In Spain, the country with highest cultivation of maize MON 
810 and therefore the largest number of surveyed farmers, no suitable sampling frame was available as 
a consequence surveyors used previous contacts. 
2)  Population included the sampling frame 
Appendix 1 of the 2011 MON 810 report did not include information on the number of farmers in the 
sampling frame. 
3)  Characteristics of the population included in the sampling frame 
Appendix 1 of the 2011 MON 810 report did not include information on the characteristics of the 
farmers included in the sampling frame. Information on the number of farmers in the sampling frame 
according to country, region, size of farm/number of fields and previous cultivation of GM crops is 
important. 
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4)  Sampling frame coverage 
Information on the sampling frame was not provided in Appendix 1 of the 2011 MON 810 report, and 
therefore  this  is  difficult  to  assess.  The  report  states  that  ´The  customer  lists  of  the  seed  selling 
companies do not completely reflect the MON 810 cultivating farmers, so that some are missing´ but 
does not try to characterise the missing farmers. Table 3.2 indicates that farmers from all the countries 
growing maize MON 810 were included in the survey. The percentage of maize MON 810-planted 
surfaces surveyed ranged between 3.8 % in Spain to 94 % in Romania. For Europe as a whole, 9.9 % 
of maize MON 810-planted surfaces were surveyed – this is a decrease from 12.5 % in 2009 and 
13.3 % in 2010. Since the survey size per year is fixed at 250 farmers and the area of maize MON 810 
cultivation has increased this proportion may continue to decrease. Full details on the source of the 
sampling frame, the number of farmers and the major characteristics of the farmers should be included 
in the survey report. The national registers set by Member States on the cultivation of GM crops would 
be the optimum sampling frame, however the report notes that when using public registers they ´do 
not necessarily contain the contact data of the farms so that it is often very difficult to identify them.´ 
Sampling method 
1)  Selection of sample units 
Appendix 1 of the 2011 MON 810 report states public registers and customer lists of the seed selling 
companies have been used as sampling frames in 2011, but in one country no sampling frame was 
available. Survey design methodology requires the sampling frame to be representative for the target 
population, in this case European farmers growing MON 810, and that the random selection process is 
applied  to  the  sample  units  in  the  sampling  frame  prior  to  proceeding  with  the  interviews.  A 
description of the method to ensure that units are randomly selected from the sampling frame should 
be included in the report, including where relevant the statistical software and/or the program code 
used for this procedure. 
2)  Sampling of units from representative environments 
Appendix 1 of the 2011 MON 810 report states ´two strategies for selecting farmers are applied: in 
MS with a high rate of market penetration a certain number of farms will be selected whereas in MS 
with low cultivation rates preferably all MON 810 cultivating farmers are interviewed.´ This differs 
from the 2010 MON 810 report which stated: ´For selecting farmers in countries with higher market 
penetration a procedure is applied to select: at least 10 % of farmers and 10 % GM area per region and 
at least 20 % of new farmers each year.´ To ensure units are selected from representative environments 
(regions with high uptake of maize MON 810), a proportion of farmers to be selected from each strata 
(e.g. country) should be clearly defined and consistently applied in each year of the survey. 
3)  Proportion of sample units selected 
The number of farmers surveyed in each country is provided, but no indication of the total number of 
farmers in each country and region included in the sampling frame is given. Table 3.2 describes the 
proportion of maize MON 810-planted area covered in the survey, it can be seen that in 2011 there are 
no countries where all farmers where surveyed. Information on the farmers included in the sampling 
frame and selected from the sampling frame should be provided as evidence that the sampling method 
has been successfully implemented. 
4)  Selection bias 
If the number of farmers cultivating maize MON 810 increases, it will be difficult to ensure all farmers 
within a region are interviewed as a consequence an appropriate sampling methodology becomes more 
important. The report provides limited information on the sampling methodology and the possibility of 
selection bias and achievement of adequate power in the survey cannot be excluded. The grouping of 
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be performed using the specified sampling frame prior to conducting the interviews. A description of 
the method to ensure that units are randomly selected from the sampling frame should be included in 
the report, including where relevant the statistical software and/or the program code used for this 
procedure. The proportion of new farmers and farmers with previous experience of maize MON 810 
selected from the sampling frame for each region should be presented in the report to provide evidence 
that the sampling method ensures that areas of intensive maize MON 810 cultivation are appropriately 
covered in the survey. 
Sample size 
1)  Size of the adverse effect 
Appendix 1 of the 2011 MON 810 report states that the null hypothesis is that the proportion of 
responses that are not ´as usual´ is above 10 %. Therefore, the threshold or margin for adverse effects 
is 10 % (i.e. 5 % above the baseline). No specific reference from the scientific literature was provided 
to support the selection of 10 %; however, for this type of study 10 % represents an acceptable limit of 
change. A 10 % effect size has also been selected in a framework proposal for post-release monitoring 
of second-generation crops with novel traits in Canada (Beckie et al., 2010). 
2)  Type I error rate 
The type I error rate is α = 0.01 in Appendix 1 of the 2011 MON 810 report. This denotes that there is 
a 1 % probability of rejecting the null hypothesis that there is a „proportion of adverse effects greater 
than 10%‟ when it is true, i.e. failure to detect a true adverse effect. A type I error rate of 1 % is 
conservative and acceptable. 
3)  Type II error rate 
The type II error rate is β = 0.01 in Appendix 1. This denotes that there is a 1 % probability of 
accepting the null hypothesis that there is a „proportion of adverse effects greater than 10%‟ when it is 
false, i.e. falsely detecting an adverse effect. The selection of 0.01 will result in a large sample size. 
4)  Reference for the sample size method 
The sample size calculation was performed using the methodology described in Rasch et al. (2007). 
5)  Sample size calculation 
Sample size calculation is as reported in the 2009 and 2010 monitoring reports. The sample size is 
calculated assuming difference testing. 
 
6)  Sample size 
As concluded for the 2009 and 2010 monitoring reports, the selection of parameters for the sample 
size calculation is conservative, and consequently the resulting sample size is large. In 2011, 249 
farmers were sampled – this is one farmer less than the planned 250 farmers per year. Nonetheless, it 
is likely that the same farmer may be surveyed in different years and therefore sample units may not 
be independent from each other. Consideration of this factor should be included in the sample size 
calculation. Most importantly, the power of the study will be achieved only when the sample size of 
2500 farmers/fields surveyed is achieved after 10 years. 
Survey response rate 
1)  Follow-up for non-responders 
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Appendix 1 of the 2011 MON 810 report states ´The surveys are performed after the planting season, 
the farmers are provided with a copy of the questionnaire at least two weeks before a telephone 
interview  or  interviewed  face-to-face.´  This  should  reduce  the  number  of  non-responders  in 
comparison with other survey methods. No information is provided in the report on the follow-up for 
non-responders. 
2)  Response rate 
The response rate is not provided, however in Appendix 1 of the 2011 MON 810 report the fact that 
ten farmers from the Czech Republic refused to participate is recorded. 
3)  Losses in sampling 
No details of losses in sampling are included in the report. The number of farmers selected from the 
sampling frame but not contacted by the interviewers should be stated in the report. 
4)  Partial responses and reasons for non-completion 
This information was not presented in the report; however, the use of trained interviewers may have 
resulted in no cases of partial completion of the survey. 
5)  Characteristics of responder group and non-responder group 
This information was not included in the report. It is important to know if a specific subgroup of 
farmers is not participating in the survey and therefore is not represented in the survey findings; 
consequently, this comparison should be presented in the report. 
6)  Characteristics of responder group compared with the target population 
No comparison between the responder group and the target population is provided in the report. Where 
available,  national  registers  for  the  cultivation  of  GM  crops  should  be  compared  with  the 
characteristics of the farmers surveyed in terms of geographical location and farming practices to 
ensure that the farmers surveyed are representative of the target population. 
7)  Non response bias 
The losses to sampling should be fully documented in the report to provide evidence that there is no 
non-response bias. It is important to know if a specific subgroup of farmers is not participating in the 
survey and therefore is not represented in the survey findings. 
Instrument design 
1)  Interviewer bias 
The  2011  MON  810  survey  used  third  parties  to  perform  the  interviews,  with  the  exception  of 
Romania, where Monsanto field representatives assisted the farmers to fill in the questionnaire. The 
use of third-party interviewers can prevent interviewer bias. 
2)  Interviewer training 
Appendix  1  states  that  ´all  interviewers  have  been  trained  to  understand  the  background  of  the 
questions´, and mentions that the interviewers also draw on previous experience in administering  the 
questionnaire to ensure that the questions are completed correctly. In addition, a ´user‟s  manual´ is 
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3)  Question type 
The  questionnaire  contains  27  closed  questions,  which  require  a  comparison  between  the 
representative GM maize field and the representative conventional maize field. For these questions the 
response options are “´the same´ or ´different/changed´ ” or “ ´as usual´ or ´worse´ or ´better´ ”. It is 
these questions that are primarily analysed in the report. Where the response is not ´same/as usual´, 
there is an option to provide more details as free text. There is also a mix of closed and open questions 
to gather additional information about the farming practices on the farm and five closed questions to 
gather  information  about  good  agricultural  practice  and  implementation  of  non-Bt  refuge(s).  The 
combination of open and closed questions allows quantitative analysis of the comparisons between the 
GM maize field and the conventional maize field, and, where differences occur between the two field 
types, explanatory analysis can be performed using the information from the free text questions. 
4)  Phrasing of questions 
The questionnaire uses questions based on farm records and should be understood by a grower. 
5)  Independent and objective responses 
Overall, the questionnaire seeks to obtain an objective set of responses to summarise the results and 
experiences during the growing season for maize. Nevertheless, the questionnaire could be improved 
by  adjusting  the  balance  between  crop  performance  questions  and  questions  on  the  general  farm 
environment by addressing the latter more fully. 
6)  Comparator 
The  questionnaire  relies  on  a  comparison  between  a  representative  GM  maize  field  and  a 
representative conventional field to in order to detect unanticipated adverse effects. Consequently, the 
choice of representative fields and the recollection of similarities and differences is crucial to the 
success of the survey. The report provides no indication about the comparator fields selected by the 
farmer  for  comparison  in  the  survey,  however  Figure  3.3  of  mean  percent  of  maize  MON  810 
cultivation area of total maize area per farmer appears to indicate that on all farms some non-GM 
maize  is  grown  that  may  be  suitable  as  a  comparator.  It  is  recommended  that  the  questionnaire 
contains questions to record whether the comparator field is growing on the same farm at the same 
growing season and the variety of the comparator. If no comparators are being grown spatially or 
temporally close to the GM crop, then the rationale for selecting another comparator (e.g. maize grown 
in previous years) should be fully described. The comparators selected by the farmers for the survey 
should be summarised in the report. 
7)  Validation of the instrument 
The questionnaire was developed by the German Federal Biological Research Centre for Agriculture 
and Forestry and maize breeders and statisticians in Germany, and the results of the pilot of this 
questionnaire were published in 2004 (Wilhelm et al., 2004). The questionnaire was used in annual 
monitoring reports in the period 2006–2011. Any future amendments to the questions should be made 
giving consideration to pooled analysis of the results over 10 years. 
Instrument validity 
1)  Content validity 
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Background  data  relating  to  geographical  location  at  country  and  county  level,  surrounding 
environment, soil type, crop rotations in the previous 2 years and fertiliser treatments and irrigation is 
collected by the questionnaire. It would be of value to take longitude and latitude measurements of the 
representative GM maize field; information of this nature would facilitate linkage with other spatial 
monitoring datasets. In addition, the questionnaire should record for how many years the farmer has 
been growing maize MON 810 on the farm, and the question on crop rotation should also record, for 
rotations in which maize was grown, whether this was GM or conventional maize. 
-  Data informing on possible change in behaviour and performance of the GM crop 
The  following  characteristics  were  monitored to  obtain data  on  any  change  in  the  behaviour  and 
performance of maize MON 810: crop rotation, time of planting, tillage and planting technique, insect 
control  practices,  weed  control  practices,  fungal  control  practices,  fertiliser  application,  irrigation 
practice, time of harvest, germination vigour, time to emergence, time to male flowering, plant growth 
and  development,  incidence  of  stalk/root  lodging,  time  to  maturity,  and  yield.  It  is  noted  that 
information on plant protection products applied to the GM maize field was collected, but the same 
information was not supplied for the conventional field. In order to fully explain changes in plant 
protection product use, the products applied to the conventional field should also be recorded, and the 
quantities applied over the season to the GM maize field and the comparator field should be recorded. 
-  Data informing on possible ecological/environmental impacts of the GM crop on the 
protection goals and measurement 
The  following  characteristics  were  monitored  to  obtain  information  on  possible 
ecological/environmental impacts of maize MON 810 on protection goals: occurrence of MON 810 
volunteers, disease susceptibility, insect pest control (O. nubilalis), insect pest control (Sesamia spp.), 
pest susceptibility, weed pressure, occurrence of insects, occurrence of birds, occurrence of mammals. 
For the closed questions on occurrence of insects, birds and mammals, the option ´Do not know´ is 
included; however, it has been excluded in other closed analysis questions, forcing the farmer to make 
a clear assessment. Allergenicity in people handling the GM crop during production and harvesting 
could be an adverse effect: a question to assess this should be included in the questionnaire. It is 
important that the question is phrased in such a way that it discriminates between allergenicity to the 
GM crop and background levels of hay fever type symptoms. 
-  Compliance with good agricultural practice 
Section 4 requests information on compliance with good agricultural practice, and in this case the 
planting of non-Bt refuge(s). 
2)  Criterion validity 
The scientific opinion of the EFSA GMO Panel on the renewal of the authorisation for maize MON 
810 commercialisation in the EU (EFSA GMO Panel, 2009) states that ´The information available in 
the renewal applications gives no reason to change the opinion that maize MON 810 is agronomically 
and phenotypically equivalent to currently grown non-GM maize varieties, with exception of the insect 
resistance conferred by the Cry1Ab protein.´ The 2005 scientific opinion for maize MON 863 × MON 
810 × NK603 (EFSA GMO Panel, 2005) states ´Plants of the same field trials as for compositional 
analysis, except for a difference in glyphosate treatment (see section 3.2.2) were compared for their 
agronomic and phenotypic characteristics. These characteristics included seedling vigour, crop growth 
stages (for example, the stage at which silking and pollination occurred), height of the plant and ear 
(attachment containing the cob and kernels), root lodging (plants leaning to the surface), stalk lodging 
(plants with stalks broken below the ear), dropped ears, final stand count, stay-green and kernel yield. 
The  plants  tested  showed  no  particular  deviations  in  any  of  these  parameters.  In  addition,  plant 
damage due to insect feeding in two locations and due to weather in one location appeared to occur Scientific Opinion on 2011 Monsanto PMEM report on GM maize MON 810  
 
 
EFSA Journal 2013;11(12):3500  32 
preferentially  in  plots  planted  with  reference  lines.´  Report  MSL-18567  (Carringer  et  al.,  2004) 
includes data on the agronomic parameters assessed in the above opinion. In the case of seedling 
vigour, both maize MON 810 and the reference varieties had ´excellent´ vigour, with the exception of 
one site where one reference variety was classed as poor and one as average. Stalk lodging in plants 
near harvest was observed more frequently in the reference varieties, and at one site root lodging in 
plants close to harvest was observed more frequently in the reference varieties. In the case of the other 
agronomic parameters, there was no particular deviation between maize MON 810 and the reference 
varieties. Appendix 1 of the 2011 MON 810 report assessing the characteristics of maize MON 810 
reported ´unchanged germination, unchanged time to emergence, unchanged time to male flowering, 
unchanged  plant  growth  and  development,  lower  incidence  of  stalk/root lodging,  delayed  time  to 
maturity, higher yield and lower occurrence of MON 810 volunteers.´ Comparing the field trial data 
with the farmer survey data provides an opportunity to check the validity of the farmers‟ responses. It 
appears that there may be differences between field trial data and the questionnaire: there are a number 
of possible explanations for this, e.g. the conventional crops grown on the farms differ from the 
comparator  variety  used  in  the  field  trials,  the  information  provided  by  the  farmers  is  biased  or 
erroneous or the GM crop is performing differently on farm-scale cultivation (possibly performing 
better  when  the  cultivation  conditions  are  less  than  optimal).  It  is  of  value  to  select  parameters 
measured using a ´gold standard´ methodology and to contrast these with the responses in the survey 
to ensure the validity of the reported responses. 
3)  External consistency 
Comparison  of  the  data  reported  in  the  survey  with  information  from  independent  data  sources 
provides a further opportunity to test the validity of the responses. The information on soil quality 
offers the opportunity to compare it with the information held in the Soil Profile Analytical Database 
for Europe (SPADE-2) (Hollis et al., 2006). Figure 1 shows the information on top soil organic carbon 
contained in this database. The MON 810 survey reports organic carbon content values between 0.58 
and 7.27 with a mean of 2.2. It can be seen that this range falls within that of the SPADE-2 range for 
organic carbon content. It should be noted that the SPADE-2 database provides a useful dataset for 
European soil properties but that the values are based on a limited set of soil samples for each EU 
country. 
 
Figure 1:   Distribution and descriptive statistics of top soil organic carbon contents in SPADE-2 
forfree-draining non-organic soils. 
4)  Plausibility of responses 
The sowing and harvest times were used to check the plausibility of the responses provided by the 
farmers: the sowing time ranged from 1 March 2011 to 30 June 2011 and the harvest time from 1 
August 2011 to 31 December 2011. 
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The questionnaire is able to detect changes in characteristics of the GM maize field compared with the 
conventional  field  that  could  be  predicted  when  the  nature  of  the  genetic  event  in  MON  810  is 
considered. Maize MON 810 expresses the cry1Ab coding sequence, which encodes an insecticidal 
protein, Cry1Ab. The responses to the survey indicated that, for the maize MON 810 field, insecticide 
application and corn borer control practices were different: owing to a reduction in insecticides applied 
to control corn borers, the yield was higher, there was a lower incidence of root and stalk lodging and 
less susceptibility to diseases and pests. The questionnaire also indicated that the control of ECB and 
pink  borer  in  maize  MON  810  fields  was  very  good.  The  report  proposes  that  the  change  in 
characteristics is due to the increased protection from corn borer damage. This hypothesis is credible 
and indicates consistency and agreement among outcome variables. 
Data validation 
1)  Validation procedures 
Section 2.7 of Appendix 1 describes the data management and quality control procedures. It states that 
´For not readable entries in the questionnaires, queries were formulated and the field representatives or 
farmers were asked for explanation. These entries in the database were corrected´. The number of 
questionnaires that require further clarification with the farmers should be included in the report, 
including a classification by error types. 
2)  Exclusion of results 
All completed questionnaires (249) were included in the analysis. 
3)  Missing values 
In the analysis of each of the monitoring characteristics, the number of responses for each value was 
shown  in  the  table,  including  the  missing  values  where  they  occur.  With  the  exception  of  the 
occurrence of wild fauna questions, there were very few missing values. 
Longitudinal aspects 
1)  Sampling over multiple years 
The repeated sampling of a sample unit needs to be considered in the sample size calculations and in 
the statistical analysis of the results. It is important that a mechanism for recording repeated sampling 
is introduced and the numbers of sample units repeatedly sampled are included in the report. If this 
information were available, it would allow an analysis considering the intensity of maize MON 810 
cultivation  and  the  possible  changes  in  monitoring  characteristic  assessment  as  maize  MON  810 
cultivation is repeated in consecutive years. 
Statistical analysis 
1)  Objective and hypotheses 
Appendix 1 states ´The aim of the survey is to identify potential adverse effects that might be related 
to  MON  810  plants  and  their  cultivation.  For  that  reason,  most  questions  are  formulated  to  get 
ordinary data, i.e. with three possible answers (Plus/ As usual/ Minus). The Plus- and Minus-answers 
indicate a deviation from the situation with conventional maize and are provided with a specification 
to describe the specific effect and its potential cause. High frequency (> 10 %) of Plus or Minus- 
answers would indicate possible effects.´ 
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Section 2.4 of Appendix 1 describes the statistical test procedure. The effect is specified as a 5 % 
increase from the baseline of 5 %, setting the threshold for responses that are not ´as usual´ at 10 %. It 
would be expedient to provide scientific references to support the selection of the 10 % threshold. 
Additionally,  for  certain  responses,  10  %  may  be  greater  than  the  acceptable  limit  of  change. 
Alternative statistical analyses allowing the exploration of different effect sizes for certain monitoring 
characteristics  would  assist  in  the  interpretation  of  the  results.  The  null  hypothesis  is  that  the 
proportion of responses not ´as usual´ is above 10 %. A significance level of 0.01 % was used in the 
statistical test. If p < 0.01, then the null hypothesis that the minus/plus response is greater than 10 % is 
rejected and therefore no effect can be identified. 
3)  Pre-defined subgroups 
The analysis was performed for all fields surveyed in 2011. There was no analysis of country level 
data. Given the number of farmers surveyed in some countries, analyses of country-level subgroup 
may not have been statistically valid; however, consideration should be given to the fact that Member 
States  may  require  country-level  results.  In  addition,  analysis  of  the  assessment  of  monitoring 
characteristics  by  new  farmers  compared  with  farmers  with  previous  experience  of  cultivation  of 
maize MON 810 would be of interest. This could assist in detecting residual effects. 
4)  Statistical analysis 
The reports states that plus responses and minus responses were ´statistically tested by using the exact 
binomial  test´.  This  test  is  appropriate  for  the  ´same/different´  type  of  question.  However,  for 
questions of the ´as usual or worse or better´ type, where there are three outcomes, an analysis using a 
multinomial test should be performed (in this case a trinomial test). Galyean and Wester (2010) used 
simulation methods to generate experimental count data from multinomial distributions in order to 
compare multinomial and binomial proportion methods for analysis. It was concluded that analysing 
multinomial data as a series of binomial proportions increased the experiment-wise type I error rate 
and  recommended  to  use  a  multinomial  analysis  to  test  for  the  distributional  difference  with  a 
subsequent binomial approach used to test for differences in a specific category or to correct for the 
multiplicity of testing. 
5)  Results presentation 
For each monitoring characteristic measured by the survey, a table of the responses was provided with 
percentage and ´valid percentages´ (the proportion of answers excluding missing values) plus a bar 
chart  of  the  frequency  of  responses.  The  valid  percentages  were  used  in  the  binomial  test.  The 
reasoning between the valid percentages in the table of responses and the table of the results of the 
binomial test for different ´treatments/practices´ should be further explained by the applicant in order 
to facilitate interpretation of the results. 
6)  Descriptive statistics 
Descriptive statistics were provided for the continuous outcome values number of fields, maize area in 
hectares, percentage humus content, sowing date and harvest date. The analysis of the categorical 
values was provided as frequency tables. 
7)  Multiplicity 
A significance level of 0.01 was used, but the issue of multiplicity of testing was not addressed. 
Another major problem is related to the fact that the analysis needs to be pooled after 10 years to 
achieve the statistical power described in the sample size calculations. Each annual report represents 
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8)  Handing missing values 
In the tables two percentages were presented: the ´Percent´, which included missing values, and the 
´Valid percentages´, in which the missing data or the ´Don‟t know´ responses were excluded. 
9)  Confidence intervals 
For statistical tests it is standard practice to use confidence intervals, and these were not included in 
Appendix 1. In the table summarising the analysis of the monitoring characteristics (e.g. Table 3.1 in 
Appendix 1) the confidence intervals should be included. The inclusion of confidence intervals would 
allow an understanding of the sensitivity of the analysis to the choice threshold. 
10) Post-hoc analysis 
Post-hoc analysis was performed only when an effect was identified and further explanatory analysis 
was possible using less structured information, e.g. free text collected in the questionnaire. 
Report conclusions 
1)  Report conclusions 
Appendix 1 contains the following conclusions: 
2011 data indicates that in comparison to conventional maize plants, maize MON 810 plants 
-  received  less  insecticides  caused  by  their  inherent  protection  against  certain  lepidopteran 
pests, 
-  had  less  incidence  of  stalk/root  lodging  caused  by  the  inherent  protection  against  certain 
lepidopteran pests, 
-  had a longer time to maturity caused by the absence of pest pressure of certain lepidopteran 
pests, 
-  gave a higher yield caused by the better fitness of the plant, 
-  were observed less as volunteers from previous year‟s planting caused by a more effective 
previous year‟s harvest, 
-  were less susceptible to diseases caused by hardly any insect feeding damage, 
-  controlled corn borers very well caused by the inherent protection against certain lepidopteran 
pests, and 
-  were less susceptible to pests, other than corn borers, especially lepidopteran pests caused by 
the inherent protection against certain lepidopteran pests and the resulting better fitness of the 
plants. 
2)  Study design 
The study design was appropriate to evaluate whether a set of monitoring characteristics relating to 
plant performance and management practices for maize MON 810 cultivation in the current year of the 
survey differed from a comparator variety by a threshold of 10 %. However there are indications of 
weaknesses in the sampling methodology applied for the survey and as a consequence the possibility Scientific Opinion on 2011 Monsanto PMEM report on GM maize MON 810  
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of selection bias in the survey cannot be excluded. In addition the result of this assessment was very 
much dependent on the selection of an appropriate comparator.  
Certain effects may reach a sufficient magnitude for detection only with repeated cultivation of a GM 
crop, and so amendments to study design and the analysis plan should be considered in order to assess 
the effect of multiple years of GM crop cultivation. Table 4.1 in Appendix 1 presents the results from 
the previous five years and the 2011 results. The inclusion of the pooled results would be of interest. 
3)  Substantiation of results 
Sixty-two  farmers  (25  %)  indicated  that  that  they  had  changed  the  application  procedure  for 
insecticides  in  the  maize  MON  810  field;  these  were  farmers  who  usually  used  insecticides 
specifically to control corn borers. Sixty-one farmers (25 %) reported a reduction in stalk and root 
lodging in the maize MON 810 field compared with the conventional field. A reduction in stalk and 
root lodging was also observed in the field trial studies. Thirty-two farmers (13 %) reported delayed 
maturity. Forty-nine farmers (20 %) reported that the maize MON 810 field was less susceptible to 
diseases, with associated reports of reduced susceptibility to Fusarium spp. (36 farmers) and Ustilago 
maydis (24 farmers). The reports of reduced susceptibility to fungal infections were substantiated with 
similar findings from the scientific literature. Two hundred and fourteen farmers (86 %) and 166 
farmers (valid percentage 86 %) reported that maize MON 810 provided ´very good´ control of ECB 
and pink borer, respectively, and 44 farmers (18 %) reported maize MON 810 to be less susceptible to 
pests other than the borers. These results are to be expected, as the genetic modification provides 
protection from corn borers and therefore should result in a healthier crop. An increased yield was 
reported by 108 farmers (43 %); as maize MON 810 has less insect damage, an increased yield is not 
unexpected. Seventeen farmers (7 %) reported a lower occurrence of volunteers. 
For the monitoring characteristics above, the report states that the effect was greater than 5 % plus the 
5 % baseline, and the null hypothesis that an effect was evident could not be rejected. Presenting the 
results with confidence intervals would have facilitated the interpretation of the results and allowed the 
effect of the selection of alternative threshold values other than the arbitrarily selected 10 % to be 
explored. 
The monitoring characteristics that were not ´as usual´ described above were also observed in the 2009 
and 2010 monitoring reports. In 2011 not ´as usual´ responses above the 10 % threshold related to time 
of harvest, germination vigour and plant growth and development were not observed, however these 
may be dependent on the growing conditions in a particular year. The consistency of the results in 
each year of survey indicates the stability of the observed effects. Interpretation of the results should 
be viewed with caution as there are indications of weaknesses in the sampling methodology applied 
for the survey and as a consequence the possibility of selection bias in the survey cannot be excluded. 
The number of farmers cultivating maize MON 810 is increasing and in 2011 there were no regions 
where a census survey was performed as consequence it is becoming increasingly essential that an 
appropriate and consistent sampling methodology is used. The grouping of sample units according to 
the strata and random selection of sample units from within the strata should be performed using the 
specified sampling frame prior to conducting the interviews. A description of the method to ensure 
that units are randomly selected from the sampling frame should be included in the report, including 
where relevant the statistical software and/or the program code used for this procedure. The proportion 
of new farmers and farmers with previous experience of maize MON 810 selected from the sampling 
frame for each region should be presented in the report to provide evidence that the sampling method 
ensures that areas of intensive maize MON 810 cultivation are appropriately covered in the survey. 
Recommendations and Conclusions 
From the data provided in the 2011 survey from the farmer questionnaire to monitor adverse effects 
associated with the cultivation of maize MON 810, no adverse effect can be identified. However the Scientific Opinion on 2011 Monsanto PMEM report on GM maize MON 810  
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2011 report provides limited information on the sampling methodology and the possibility of selection 
bias in the survey cannot be excluded. Therefore, the following improvements to the survey design 
and reporting are recommended: 
-  Full  details  on  the  source  of  the  sampling  frame,  the  number  of  farmers  and  the  major 
characteristics  (e.g.  previous  cultivation  of  maize  MON  810)  of  the  farmers  should  be 
included in the survey report. The national registers set by Member States for the cultivation 
of GM crops would be the optimum sampling frame, if available. 
-  A description of the method to ensure that units are randomly selected from the sampling 
frame should be included in the report, including where relevant the statistical software and/or 
the program code used for this procedure. The proportion of new farmers and farmers with 
previous experience of maize MON 810 selected from the sampling frame for each region 
should be presented in the monitoring report to provide evidence that the sampling method 
ensures that areas of intensive maize MON 810 cultivation are appropriately covered by the 
survey. 
-  The losses to sampling should be fully documented in the report to provide evidence that there 
is no non-response bias. It is important to know if a specific subgroup of farmers is not 
participating in the survey and therefore is not represented in the survey findings; 
-  It is recommended that independent trained interviewers are used to reduce interviewer bias. 
-  It  is  recommended  that  the  farmer  questionnaire  contain  questions  to  record  whether  the 
comparator field is growing on the same farm in the same growing season and the variety of 
the comparator. If no comparators are being grown spatially or temporally close to the GM 
crop, then the rationale for selecting another comparator (e.g. maize grown in previous years) 
should be fully described. The comparators selected by the farmers for the survey should be 
summarised in the monitoring report. 
-  Farmer questionnaires should focus only on changes that would be recognised by the farmer 
during the daily management of the farm. However, additional questions could be included to 
gain a better understanding of the intensity of GM maize cultivation on the farm (number of 
years of maize MON 810 cultivation and frequency of maize MON 810 in crop rotations), and 
further information on plant protection product usage (in particular, in the comparator field) 
should be obtained to facilitate a full understanding of any observed changes. 
-  Confidence intervals for the analysis of the monitoring characteristics should be included in 
the statistical report. Presenting the results with confidence intervals would have facilitated 
their interpretation and allowed the effect of the selection of alternative threshold values other 
than the arbitrarily selected 10 % to be explored. The choice of statistical test should be based 
on the number of possible outcomes, the use of a series of binomial tests for multinomial 
distributions would increase the experiment-wise type I error rate (i.e. failure to detect a true 
adverse effect). 
-  The  statistical  analysis  should  be  planned  to  allow  an  analysis  of  the  monitoring 
characteristics  according  to  the  length  of  GM  crop  cultivation in  order  to  assess  residual 
effects. As the statistical power of the study will be achieved only after 10 years, this will 
require a pooled analysis. Consequently, when conducting the survey, consideration should be 
given to the consistency of questions to assess monitoring characteristics, the inclusion of the 
same farmers in consecutive years in the survey (and the enumeration of these farmers in the 
report) and the interim analyses performed for the annual reports. Scientific Opinion on 2011 Monsanto PMEM report on GM maize MON 810  
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-  The presentation of the results reported in Appendix 1 of the report should be improved in 
order to facilitate their interpretation. 